Search Results 151-160 of 16867 for Amphotericin B

  1. Bispecific antibody therapy - Care at Mayo Clinic

    2022; doi:10.1038/s41577-021-00547-6. Derman B, et al. Real-world evidence evaluating teclistamab in patients with relapsed/refractory multiple myeloma: A ...

  2. General Internal Medicine - Doctors - Mayo Clinic

    Bartlett, M.B., B.Ch., B.A.O.. Internist. Rochester, MN. Areas of focus: Antiphospholipid syndrome, Deep vein thrombosis, Pulmonary ...

  3. LS1681: A Study of AR160 in Treating Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    Giving paclitaxel albumin-stabilized nanoparticle formulation and rituximab may work better in treating patients with B-cell non-Hodgkin lymphoma. Participation ...

  4. Crohn's disease - Doctors and departments - Mayo Clinic

    Displaying 1-2 out of 2 doctors available. Last Name Initial: B ...

  5. Publications - Ibrahim Khambati, M.D., M.B.A. - Mayo Clinic

    Forsythe P, Wang B, Khambati I, Kunze WA. Systemic effects of ingested Lactobacillus rhamnosus: inhibition of mast cell membrane potassium (IKCa) current ...

  6. Appendix cancer - Doctors and departments - Mayo Clinic

    Displaying 1-1 out of 1 doctors available. Last Name Initial: B ...

  7. Clinical trials - Oncology (Medical)

    Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Fertility Outcomes in Lymphoma Patients.

  8. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    ... B-cell Non-Hodgkin Lymphomas. Print details. Share; Facebook · Twitter. Overview ... Subjects positive for hepatitis B surface antigen and/or anti-hepatitis B ...

  9. Publications - John C. Schupbach, M.D., M.B.A. - Mayo Clinic

    ... B, Mullan A, Cabrera D. FDA-reviewed artificial intelligence-enabled products applicable to emergency medicine. Am J Emerg Med. 2025 Mar; 89:241-246 Epub ...

  10. Hematology - Clinical trials

    This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers.